肝硬化、原发性肝癌患者血清抗-HCV相关性的初步探讨  

THE RELATIVITY BETWEEN HEPATIC CIRRHOSIS,PRIMARY HEPATIC CARCINOMA AND SERUM ANTI-HCV

作　　者：刘春荣[1] 刘东屏[1] 蔡至道[1] 石田[1] 董丽君[2] 

机构地区：[1]中国医科大学附属第一医院消化内科 [2]中国医科大学附属笫一医院病毒室

出　　处：《中国医科大学学报》1993年第3期219-221,共3页Journal of China Medical University

摘　　要：采用ELISA方法,对48例肝硬化患者、47例原发性肝癌患者、12例慢性肝炎患者及8例急性黄疽型肝炎患者进行血清抗-HCV检测。结果麦明:原发性肝癌组其血清抗-HCV阳性与输血无密切关系,而肝硬化组血清抗-HCV阳性与输血关系密切。两组间抗-HCV阳性率无明显差异,但与对照组差异显著。Serum anti-HCV was examined in 48 patients with hepatic cirrhois, 47 patients with primary heratic carcinoma, 12 patients with chronic hepatitis B and 8 patients with acute jaundice hepatitis. The results showed that the positive ratio of anti-HCV antibody have no close relation with blood transfusion in patients with primary hepatic carcinoma whereas close in cirhotic group. The positive ratio of anti-HCV were the same in the two groups but significantly different with normal controls.

关 键 词：原发性肝癌 肝硬变 乙型肝炎 

分 类 号：R735.7[医药卫生—肿瘤]